The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: Natural history, diagnosis, differential diagnosis and management

Journal of Endocrinological Investigation

Volumn 24, Issue 9, 2001, Pages 659-675

  Koch, C A ^a   Sarlis, Nicholas J ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Adolescence; Childhood; Congenital; Goiter; Hyperthyroidism; Hypothyroidism; In fancy; Iodine deficiency; Levothyroxine; Radioactive iodine; Thyroid cancer; Thyroid gland; Thyroid hormone; Thyroid nodule; Thyrotoxicosis; Thyrotropin

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; GLUCOCORTICOID; HORMONE INHIBITOR; IODIDE; IODINE 131; IOPANOIC ACID; IOPODIC ACID; LUGOL; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; RECOMBINANT THYROTROPIN; SEDATIVE AGENT; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADOLESCENT DISEASE; ADULTHOOD; AGRANULOCYTOSIS; ARTHRALGIA; ATTENTION DEFICIT DISORDER; CHILDHOOD DISEASE; CONGENITAL HYPOTHYROIDISM; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GENE MUTATION; GOITER; GRAVES DISEASE; HEADACHE; HEPATITIS; HORMONE INHIBITION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INSOMNIA; MENTAL DEFICIENCY; MOLECULAR GENETICS; NAUSEA AND VOMITING; NEEDLE BIOPSY; PATHOGENESIS; PENDRED SYNDROME; PRACTICE GUIDELINE; PROGNOSIS; PUBLIC HEALTH; RASH; REVIEW; RISK FACTOR; THYROID CANCER; THYROID DISEASE; THYROID NODULE; THYROID SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY; THYROIDITIS; THYROTOXICOSIS;

ADOLESCENT; ADULT; CHILD; CONGENITAL HYPOTHYROIDISM; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT, NEWBORN; THYROID DISEASES; THYROID NEOPLASMS; THYROID NODULE;

EID: 0034768038     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343911     Document Type: Review

References (122)

1. Maturation of human hypothalamic-pituitary-thyroid function and control
2. Thyroid disease
3. Molecular mechanisms of dominant negative activity by nuclear hormone receptors
4. Prediction and therapy of intrauterine and late onset neonatal hyperthyroidism
5. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies
6. Ocular manifestations in children and adolescents with thyrotoxicosis
7. Special features of Graves' disease in early childhood
8. Juvenile Graves' disease: The usefulness and limitations of thyrotropin receptor antibody determination
9. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: These determinants have no homologous sequence on gonadotropin receptors
10. Thyrotoxicosis in children: Thirty years' experience
11. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine
12. Thyrotoxicosis in childhood
13. Current therapeutic approaches to hyperthyroidism
14. Administration of thyroxine in treated Graves' disease
15. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug
16. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil
17. Surgery for Graves disease in childhood and adolescence
18. Issues and epidemiological evidence regarding radiation-induced thyroid cancer
19. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism
20. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism
21. Constitutively activating TSH-receptor mutations as modulator cause of non-autoimmune hyperthyroidism in childhood
22. Islet cell and other organ-specific antibodies in US caucasians and blacks with insulin-dependent diabetes mellitus
23. Subacute thyroiditis in a lateral thyroid gland: Evaluation of the pituitary-thyroid axis during the acute destructive and the recovery phases
24. Subacute de Quervain's thyroiditis: Association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins
25. Acute suppurative thyroiditis in children
26. A fistula from pyriform sinus inn recurrent acute suppurative thyroiditis
27. Acute suppurative thyroiditis in pediatric patients
28. The syndromes of resistance to thyroid hormone
29. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study
30. Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health
31. Solitary polyclonal autonomous thyroid nodule: A rare cause of childhood hyperthyroidism
32. Levothyroxine ingestions in children: An analysis of 78 cases
33. Infantile hypothyroidism then and now: The results of neonatal screening
34. Intellectual development at age 12 years of children with congenital hypothyroidism diagnosed by newborn screening
35. Long-term effects of L-thyroxine therapy for congenital hypothyroidism
36. Incidence of congenital hypothyroidism: Retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis
37. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia
38. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
39. Congenital hypothyroidism caused by mutations in the thyrotropin-receptor gene
40. Sequential serum measurements of thyrotropin binding inhibiting immunoglobulin G in transient neonatal hypothyroidism
41. Congenital hypothyroidism: Etiologies, diagnosis, and management
42. Iodine nutrition in the United States: Trends and public health implications: Iodine excretion data from the National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994)
43. Inborn errors of thyroid hormone biosynthesis
44. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS)
45. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3′ splice site
46. Familial hypothyroidism caused by a nonsense mutation in the thyroid-stimulating hormone beta-subunit gene
47. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene
48. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH
49. Thyroid in the newborn and infant
50. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
51. Clinical review 19: Management of congenital hypothyroidism
52. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism
53. Longitudinal assessment of L-thyroxine therapy for congenital hypothyroidism
54. Newborn screening for congenital hypothyroidism: Recommended guidelines
55. Age-related changes in serum free thyroxine during childhood and adolescence
56. The later growth of the brain and its vulnerability
57. Brief report: Acquired autoimmune-mediated infantile hypothyroidism: A pathologic entity distinct from congenital hypothyroidism
58. Autoimmune thyroiditis in childhood-epidemiology, clinical and laboratory findings in 61 patients
59. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease
60. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus
61. Positional cloning of the APECED gene
62. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
63. Postradiotherapy hypothyroidism: Radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy
64. Growth and endocrine disorders secondary to cranial irradiation
65. Recent developments in pediatric thyroidology
66. Pituitary-thyroid feedback hypersensitivity as a novel cause of hypothyroidism in children
67. Adolescent thyroid disorders
68. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer
69. Neonatal hypothyroidism: Treatment and outcome
70. Progressive sensorineural hearing loss and a widened vestibular aqueduct in Pendred syndrome
71. Pendred's syndrome: Identification of the genetic defect a century after its recognition
72. Ectopic lingual thyroid: An otolaryngologic emergency beyond childhood
73. Thyroid nodules and carcinoma in Graves' disease
74. Thyroid nodules in the follow-up of irradiated individuals: Comparison of thyroid ultrasound with scanning and palpation
75. Thyroid nodules in childhood and adolescence - Thirty years of experience
76. Inverse association between age at the time of radiation exposure and extent of disease in cases of radiation-induced childhood thyroid carcinomas in Belarus
77. Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: Statistical data and clinicomorphologic characteristics
78. Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease
79. Medullary thyroid carcinoma
80. Familial nonmedullary thyroid carcinoma
81. Comparing thyroid ultrasonography to thyroid function in long-term survivors of childhood lymphoma
82. Fine-needle aspiration biopsy in the management of thyroid nodules in children and adolescents
83. Cold thyroid nodules in childhood: Is surgery always necessary?
84. Preoperative evaluation and predictive value of fine-needle aspiration and frozen section of thyroid nodules
85. Functioning thyroid nodules in childhood and adolescence
86. Childhood cancer
87. Thyroid cancer in childhood
88. Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas (Carney complex)
89. Thyroid cancer in patients with familial adenomatous polyposis
90. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
91. Papillary thyroid carcinoma (PTC) in a child with McCune-Albright syndrome (MAS): More than a random association?
92. Well-differentiated thyroid carcinomas in children and adolescents: A review
93. Solitary thyroid nodules in 93 children and adolescents. A 35-years experience
94. Evaluation of provocative tests in suspected medullary carcinoma of the thyroid: Heterogeneity of calcitonin responses to calcium and pentagastrin
95. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma
96. Comparison of pertechnetate and radioiodine thyroid scintiscans in thyroid disease
97. Localization of neuroendocrine tumours with 111In-DTPA-octreotide scintigraphy (Octreoscan): A comparative study with CT and MR imaging
98. Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group
99. Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma
100. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children
101. Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected
102. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective
103. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: Statistics following University of Michigan therapy
104. Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid carcinoma
105. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry
106. Low iodine diet in I-131 ablation of thyroid remnants
107. Differentiated thyroid carcinoma in childhood: Long-term follow-up of 72 patients
108. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer
109. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer
110. The long-term hazards of the treatment of thyroid cancer with radioiodine
111. Acute leukemias after treatment with radioiodine for thyroid cancer
112. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma
113. Thyroid carcinoma in childhood: Final report on a 20-year study
114. Differentiated thyroid cancer in children and adolescents: Clinical outcome and mortality after long-term follow-up
115. RET proto-oncogene in the development of human cancer
116. Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: Results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)
117. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
118. Familial medullary thyroid carcinoma: Presymptomatic diagnosis and management in children
119. Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management
120. Surgical management of patients with persistent or recurrent medullary thyroid cancer
121. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma
122. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels